ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,438Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 393

$540K Total Retail Price of All Prescriptions

Rank: 53 out of 393

853 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 853 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 853 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,422 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 719 688 1 2
PRAVASTATIN SODIUM 637 613 2 18
AMLODIPINE BESYLATE 502 491 3 4
SIMVASTATIN 454 415 4 1
LEVOTHYROXINE SODIUM 442 414 5 3
BENAZEPRIL HCL 360 354 6 40
LOVASTATIN 299 293 7 14
ATENOLOL 289 275 8 13
OMEPRAZOLE 270 254 9 6
LOSARTAN POTASSIUM 256 242 10 12
METFORMIN HCL ER 248 242 11 63
METOPROLOL TARTRATE 242 231 12 9
METFORMIN HCL 231 211 13 7
ZOLPIDEM TARTRATE 227 200 14 11
HYDROCODONE-ACETAMINOPHEN 222 188 S3 15 5
HYDROCHLOROTHIAZIDE 196 186 16 10
ATORVASTATIN CALCIUM 178 169 17 19
ALENDRONATE SODIUM 174 170 18 16
WARFARIN SODIUM 166 158 19 17
FLUTICASONE PROPIONATE 162 157 20 27
ALLOPURINOL 156 144 21 26
TERAZOSIN HCL 148 148 22 38
TAMSULOSIN HCL 145 136 23 25
RANITIDINE HCL 142 138 24 29
FUROSEMIDE 122 110 25 8
GABAPENTIN 119 111 26 15
GLYBURIDE 118 109 R 27 46
POTASSIUM CHLORIDE 114 97 28 20
TRIAMTERENE-HCTZ 109 101 29 49
FLUOXETINE HCL 108 94 30 37
LOSARTAN-HYDROCHLOROTHIAZIDE 95 92 31 31
CLOPIDOGREL 95 89 31 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 94 88 33 24
FINASTERIDE 85 85 34 60
DOXAZOSIN MESYLATE 84 84 35 83
FELODIPINE ER 82 82 36 130
CARVEDILOL 78 75 37 21
AMLODIPINE BESYLATE-BENAZEPRIL 71 71 38 108
TRIAMCINOLONE ACETONIDE 70 56 39 94
METHYLPREDNISOLONE 70 64 39 80
LANTUS 69 64 41 73
GLIPIZIDE 67 67 42 32
OXYCODONE HCL 64 30 S2 43 36
LIPITOR 62 62 44 123
PLAVIX 62 62 44 51
GEMFIBROZIL 57 57 46 62
DIGOXIN 57 55 46 66
BISOPROLOL-HYDROCHLOROTHIAZIDE 56 44 48 136
AZITHROMYCIN 56 50 48 35
MELOXICAM 54 53 50 58
IBUPROFEN 50 44 51 55
METOPROLOL SUCCINATE 50 46 51 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.